Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Rocky Mountain Poison and Drug Center, Denver Health and Hospital Authority, Denver, CO.
J Pediatr. 2018 Jul;198:254-259.e1. doi: 10.1016/j.jpeds.2018.02.033. Epub 2018 Apr 2.
To assess the temporal association of flow restrictor introduction and the rate of accidental unsupervised ingestions (AUIs) of liquid acetaminophen products.
The National Poison Data System was used to identify AUIs of single ingredient acetaminophen in patients aged <12 years reported between 2007 and 2015. Six regional poison centers obtained additional information using a structured telephone survey.
Pediatric AUIs involving acetaminophen averaged 30 000 exposures per year between 2007 and 2012. From 2012 to 2015, after flow restrictor introduction, exposures steadily decreased at a rate of 2400 fewer exposures annually, reaching 21 877 exposures in 2015. Normalized to sales volume, exposures involving liquid acetaminophen products decreased by 40% from 2010 to 2015. Exposures involving products with flow restrictors tended to have a lower estimated ingestion per exposure, fewer exposures exceeding a 150 mg/kg acetaminophen threshold, and were associated with lower rates of hospital admissions when compared with products without restrictors. Caregivers reported improper storage and child confusion of the medicine with treats as common contributing factors to exposures.
The introduction of flow restrictors was associated with a decrease in pediatric AUIs of liquid acetaminophen products. Decreases in the dose ingested and risk of hospital admission per exposure may also have resulted. Efforts to optimize flow restrictors and increase their use with medicines associated with high pediatric overdose risk should be encouraged.
评估流量限制器引入与液体对乙酰氨基酚产品意外无人监督摄入(AUI)率之间的时间关联。
利用国家毒物数据系统,识别 2007 年至 2015 年间报告的年龄<12 岁的患者中,单一成分对乙酰氨基酚的 AUI。六个区域中毒中心通过结构电话调查获得了额外信息。
2007 年至 2012 年,涉及对乙酰氨基酚的儿科 AUI 平均每年发生 30000 次暴露。从 2012 年到 2015 年,在引入流量限制器后,暴露量以每年减少 2400 次的速度稳定下降,到 2015 年降至 21877 次。与销售量相比,涉及液体对乙酰氨基酚产品的暴露量从 2010 年到 2015 年下降了 40%。与没有限制器的产品相比,涉及带有流量限制器的产品的估计单次摄入剂量较低,超过 150mg/kg 对乙酰氨基酚阈值的暴露量较少,且住院率较低。护理人员报告说,不当储存和儿童将药物与食物混淆是导致暴露的常见因素。
流量限制器的引入与液体对乙酰氨基酚产品的儿科 AUI 减少有关。摄入剂量和每暴露剂量住院率的降低也可能是结果。应鼓励努力优化流量限制器并增加其在与高儿科用药过量风险相关的药物中的使用。